What does this video actually claim?
Dr. Yeray Raíz's Instagram reel appears to solicit ages from US followers, presumably to provide testosterone replacement therapy guidance based on age ranges. The video targets men's health with hashtags suggesting TRT recommendations.
Without seeing the actual video content, the engagement pattern suggests age-based TRT advice. This approach raises questions about whether blanket recommendations by age group align with evidence-based medicine.
The 610,000 views indicate significant reach for what appears to be medical guidance on a complex hormonal therapy.
Does age alone determine TRT candidacy?
Age is just one factor in TRT evaluation, and it's not the most important one. Symptoms matter more than numbers on a birth certificate when determining treatment need.
The American Urological Association guidelines require both low testosterone levels (typically under 300 ng/dL on two separate morning tests) and clinical symptoms like fatigue, decreased libido, or mood changes. Age ranges from 20s to 80s don't automatically qualify or disqualify someone.
Research from Bhasin et al. (NEJM, 2018) in the TRAVERSE trial studied men aged 45-80 with documented hypogonadism. The focus was on cardiovascular safety in symptomatic men with confirmed low T, not age-based prescribing patterns.
What about testosterone's natural decline?
Testosterone does decline with age, but not uniformly or predictably enough for age-based treatment protocols. The Baltimore Longitudinal Study found average decreases of 1-2% annually after age 40.
However, this decline varies wildly between individuals. Some 70-year-old men maintain higher testosterone levels than some 30-year-olds. Total testosterone ranges from 300-1000 ng/dL in healthy adult males regardless of age.
The Massachusetts Male Aging Study showed that obesity and chronic illness affect testosterone more than age alone. A healthy 60-year-old often has higher levels than an overweight 40-year-old.
What are the real TRT considerations?
Proper TRT evaluation requires comprehensive assessment, not age-based shortcuts. Blood work should include total testosterone, free testosterone, LH, FSH, and prolactin levels.
Contraindications include untreated sleep apnea, prostate cancer history, severe heart failure, and uncontrolled polycythemia. These conditions don't correlate with specific age ranges but require individual screening.
The TTrials (Snyder et al., NEJM, 2016) demonstrated benefits in men over 65 with confirmed hypogonadism, including improved sexual function and bone density. But participants were selected based on symptoms and lab values, not age alone.
What should you actually know about TRT timing?
TRT timing depends on individual health status, symptom severity, and lab results rather than chronological age. Younger men with hypogonadism may need fertility preservation strategies before starting treatment.
Older men require cardiovascular risk assessment and prostate monitoring regardless of age. The recent TRAVERSE trial found no increased cardiovascular risk in men aged 45-80, but individual risk factors matter more than age brackets.
If you're considering TRT, get proper evaluation including multiple testosterone measurements, comprehensive health screening, and discussion of risks and benefits specific to your situation. Age is relevant context, but it's not a treatment algorithm.